Theravance Biopharma and Mylan settle a patent dispute with Eugia Pharma over Yupelri, delaying generic entry until 2039.

The Nifty Pharma index jumped 1% to 21,585.35. The index increased 1.08% for the two consecutive trading sessions.

Theravance Biopharma (NASDAQ:TBPH) and partner Mylan reached a settlement agreement with Eugia Pharma over a patent dispute ...

The Nifty Pharma index closed on a negative note on Monday. Shares of Glenmark Pharmaceuticals Ltd.(up 2.78 per cent), Ajanta ...

Norway’s NBIM, India’s top foreign portfolio investor with $30.5B, slowed bulk buys in 2025, making just two deals. With top ...

IndusInd Bank posts ₹2,329 cr Q4 loss, FY25 profit down 71%; IndiGo, NTPC Green, Star Cement shine; Dixon falls, Dredging Corp soars Q4 Results May 21, 2025 Highlights: Find all the latest Q4 results ...

Mankind Pharma shareholdings: Gain valuable insights into Mankind Pharma shareholdings and ownership. Explore the shareholding pattern and information on Mankind Pharma shareholding structure ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 97,054.97 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

National Pharmaceutical Pricing Authority notifies retail prices of 41 new drugs: Gireesh Babu, New Delhi Thursday, June 5, 2025, 08:00 Hrs [IST] The National Pharmaceutical Prici ...

Most people spend their lives trying to avoid pain. Charlie Munger didn't bother. He accepted it—stared it down, lived through it, and kept going. His advice? Life is brutal sometimes. Go ahead and ...